Clinical Trial Update: A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension [Phase 3]

View source ↗

Summary

Phase 3 MRCT of tricaprilin in mild to moderately severe probable Alzheimer's disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Tricaprilin (tricaprilin)

Snippet

Sponsor: Cerecin | Conditions: Alzheimer's Disease | Phase 3 | Status: WITHDRAWN